吉布提2019-2020年恶性疟原虫pfhrp2和pfhrp3基因缺失及其与其他全球分离株的亲缘关系
在吉布提市检测1002例疑似疟疾患者样本,311份(31.0%)经PCR确诊为恶性疟原虫感染,其中296份成功基因分型。203份(68.6%)为pfhrp2-/pfhrp3-,HRP2/3抗原浓度随基因缺失相应降低;吉布提虫株与埃塞俄比亚和厄立特里亚虫株亲缘关系密切,缺失株可能在非洲之角本地新发而非输入。
要点
- 吉布提市2019-2020年恶性疟原虫pfhrp2/3缺失率高达68.6%(203/296)。
- HRP2/3抗原浓度随相应基因缺失而降低。
- 吉布提虫株与埃塞俄比亚和厄立特里亚虫株亲缘关系密切,缺失株可能为本地新发。
核心结论
- 吉布提市2019-2020年恶性疟原虫pfhrp2/3基因缺失高度流行,缺失株似乎在非洲之角本地新发而非输入。
研究设计与样本
- 研究检测了来自吉布提市疑似疟疾患者的1002份样本,进行疟原虫抗原携带检测、pfhrp2/3基因分型及7个中性微卫星测序以评估亲缘关系。
主要发现
- 311份(31.0%)样本经PCR检测为恶性疟原虫感染阳性,其中296份(95.2%)成功基因分型。
- 基因分型样本中,37份(12.5%)为pfhrp2+/pfhrp3+,51份(17.2%)为pfhrp2+/pfhrp3-,5份(1.7%)为pfhrp2-/pfhrp3+,203份(68.6%)为pfhrp2-/pfhrp3-。
- HRP2/3抗原浓度随相应基因缺失而降低。
- 吉布提恶性疟原虫与埃塞俄比亚虫株亲缘关系密切(成对GST 0.68),与厄立特里亚虫株亲缘关系密切(成对GST 0.77)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deletions of pfhrp2 and paralogue pfhrp3 (pfhrp2/3) genes threaten Plasmodium falciparum diagnosis by rapid diagnostic test. We examined 1,002 samples from suspected malaria patients in Djibouti City, Djibouti, to investigate pfhrp2/3 deletions. We performed assays for Plasmodium antigen carriage, pfhrp2/3 genotyping, and sequencing for 7 neutral microsatellites to assess relatedness. By PCR assay, 311 (31.0%) samples tested positive for P. falciparum infection, and 296 (95.2%) were successfully genotyped; 37 (12.5%) samples were pfhrp2+/pfhrp3+, 51 (17.2%) were pfhrp2+/pfhrp3-, 5 (1.7%) were pfhrp2-/pfhrp3+, and 203 (68.6%) were pfhrp2-/pfhrp3-. Histidine-rich protein 2/3 antigen concentrations were reduced with corresponding gene deletions. Djibouti P. falciparum is closely related to Ethiopia and Eritrea parasites (pairwise GST 0.68 [Ethiopia] and 0.77 [Eritrea]). P. falciparum with deletions in pfhrp2/3 genes were highly prevalent in Djibouti City in 2019-2020; they appear to have arisen de novo within the Horn of Africa and have not been imported.
引用
- Rogier E, McCaffery JN, Mohamed MA, et al. Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions and Relatedness to Other Global Isolates, Djibouti, 2019-2020. Emerg Infect Dis. 2022. PMID: 36148905. doi:10.3201/eid2810.220695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。